HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Abstract
As part of a prospective acellular pertussis (ACP) vaccine efficacy trial, 5 serum samples were obtained, over an 18-month period, from 101 ACP-vaccine recipients and 99 control subjects, to assess ACP antibody response and decay. Immunoglobulin (Ig) G and IgA antibodies to pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), and fimbriae 2/3 (FIM) were measured by enzyme-linked immunosorbant assay, and titers of agglutinin were determined. Of the subjects, 16%-19% had preimmunization values of antibodies to PT that were above the assay's limit of quantitation (LOQ); in contrast, 36%-63% of the subjects had preimmunization values of antibodies to FHA, PRN, or FIM that were above the LOQ. Substantial increases in titers of IgG and IgA antibodies to the 3 ACP antigens (PT, FHA, and PRN) were observed. Over the 18-months, the percent decay in IgG and IgA antibodies ranged from 56% to 73% and from 57% to 70%, respectively; the IgG antibody response and decay suggests that geometric mean titers likely remain above the LOQ for 2-9 years and above the threshold of detection for 4-13 years. These findings support the use of ACP booster immunizations for adolescents and adults, to provide sustained levels of antibody.
AuthorsThuan Le, James D Cherry, Swei-Ju Chang, Maria Deloria Knoll, Martin L Lee, Steve Barenkamp, David Bernstein, Robert Edelman, Kathryn M Edwards, David Greenberg, Wendy Keitel, John Treanor, Joel I Ward, APERT Study
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 190 Issue 3 Pg. 535-44 (Aug 01 2004) ISSN: 0022-1899 [Print] United States
PMID15243929 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Immunoglobulin A
  • Immunoglobulin M
  • Pertussis Vaccine
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Bacterial (blood)
  • Antigens, Bacterial (immunology)
  • Bordetella pertussis (immunology)
  • Double-Blind Method
  • Female
  • Humans
  • Immunoglobulin A (blood)
  • Immunoglobulin M (blood)
  • Male
  • Middle Aged
  • Pertussis Vaccine (administration & dosage, immunology)
  • Prospective Studies
  • Time Factors
  • Vaccination
  • Whooping Cough (immunology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: